Answers are grounded in this paper and cite their sources.
URG7 is an anti-apoptotic protein which consists of 99 amino acid residues up regulated by antigen x during the infection. The first 74 amino acids are identical to those of the multidrug resistance protein 6 (MRP6), while the acid residues from 75 to 99 are specific for URG7 protein. Immuno-informatics tools and secondary structure were carried out to identify the antigenic properties of this URG7 sequence. The 75-99 peptide was by the solid-phase method, structurally characterized by CD spectroscopy and conjugated to a protein . New Zealand white rabbits were immunized and sera were tested for anti-peptide specific antibodies by and western blot analysis. Finally ELISA test with human sera was performed. immunized with the 75-99 peptide produce antibodies that recognize both the 75-99 peptide and the 7 recombinant polypeptide. Moreover, both antigens allowed for the detection of the anti-URG7 antibodies in of healthy and HBV infected subjects although with a different discriminant threshold. Our data suggested that ELISA assay against the specific sequence of the URG7 protein allows with good sensitivity and specificity the detection of anti-URG7 antibodies in sera from HBV infected patients.
No takes yet. Share an insight, caveat, or question.
Ostuni et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: